Sponsored Post, Devices & Diagnostics

Why Digital Health Collaborations Are the Future of Medtech

Executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using real world evidence collection to support remote patient monitoring, maximize patient engagement and navigate the regulatory landscape.

Remote patient monitoring has the potential to transform the medical device industry. But it can’t happen without collaboration with digital health companies that can provide the infrastructure to gather data from these devices and generate real world evidence (RWE). In a new eBook, executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using RWE collection to support remote patient monitoring and improve patient outcomes in neurology, cardiology and orthopedic surgery. It also explores how medtech and digital health companies can collaborate to maximize patient engagement and to navigate regulatory requirements.  For example, AliveCor has used RWE to underscore the effectiveness of its cardiac monitoring technology to reduce ER and hospitalization. “Just by adding remote patient monitoring, we were able to show real-world evidence of nearly 56% reduction in emergency room use and then 68% reduction in hospitalization for patients with arrhythmia. That is powerful,” said Dr. Archana Dubey, chief clinical officer with AliveCor. Healthcare executives also share some of the advantages of collaborating with digital health companies. “I can’t walk into a CIO conversation. It’s just not our comfort zone,” said Paul Trueman, global VP for health economics and market access at Smith and Nephew. “You need a trusted partner who can do this for you and someone who’s going to speak in the right language and come up with a value proposition for that CIO in the IT department.” To download the eBook
Remote patient monitoring: How medtech and digital health can collaborate to generate RWE and transform patient care, please fill in the form below.
metamorworks, Getty Images